diabetestalk.net

Diabetes As A Disease Of Fat Toxicity

Diabetes as a Disease of Fat Toxicity

Diabetes as a Disease of Fat Toxicity

The reason people get results with low-carb high fat diet is because of the minimal effects on insulin fat provides. There is no 2 ways around it. The camp that is lying is the camp that promotes starchy and moderate to high carb as either a cure or a mean to prevent diabetes. It’s all completely just wrong.
Put it this way, you ever heard of the term “if it ain’t broke don’t fix it”? Well there is a reason the primary and go-to cure from nearly every doctor (including the mainstream western doctors) is low-carb & high fat.
The other issue is, there was a person here who wrote up a decent little spiel on how insulin and diabetes go hand in hand. It got tons of likes, and consequently the mods of this forum pulled it, because I guess it “didn’t agree” with their views. Therein lies the problem, they don’t want people to know the truth for some odd reason.
I’ll break it down in a nutshell:
Type 1 Diabetes: Insulin dependent. People are usually born with this or acquire it at a very young age. These people are usually paper thin. They need to take insulin so they can in fact store their nutrients, otherwise they starve and die.
Type 2 Diabetes: Insulin Resistant – People acquire this through bad diet and partly (possibly) pre-disposed to it at birth making them a little more likely to get it if they aren’t careful. Insulin resistant is at it sounds, the body (or cells in this case) are resistant to the insulin the body produces.
So the question is, why? Well when you think of insulin as some annoying dude who continually knocks at the door, and your ins Continue reading

Rate this article
Total 1 ratings
Insulin, glucagon and somatostatin stores in the pancreas of subjects with type-2 diabetes and their lean and obese non-diabetic controls

Insulin, glucagon and somatostatin stores in the pancreas of subjects with type-2 diabetes and their lean and obese non-diabetic controls

In type-2 diabetes, both insufficient insulin and excessive glucagon secretion contribute to hyperglycemia. We compared insulin, glucagon and somatostatin stores in pancreas obtained at autopsy of 20 lean and 19 obese non-diabetic (ND), and 18 type-2 diabetic (T2D) subjects. From concentrations and pancreas weight, total content of hormones was calculated. Insulin content was 35% lower in T2D than ND subjects (7.4 versus 11.3 mg), whereas glucagon content was similar (0.76 versus 0.81 mg). The higher ratio of glucagon/insulin contents in T2D was thus explained by the decrease in insulin. With increasing BMI of ND subjects, insulin and glucagon contents respectively tended to increase and decrease, resulting in a lower glucagon/insulin ratio in obesity. With aging, insulin and glucagon contents did not significantly change in ND subjects but declined in T2D subjects, without association with the duration of diabetes or type of treatment. The somatostatin content was lower in T2D than ND subjects (0.027 versus 0.038 mg), but ratios somatostatin/insulin and somatostatin/glucagon were not different. In conclusion, insulin stores are about 1/3 lower in T2D than ND subjects, whereas glucagon stores are unchanged. Abnormal secretion of each hormone in type-2 diabetes cannot be attributed to major alterations in their pancreatic reserves.
Glucose homeostasis mainly relies on the opposite hypoglycemic and hyperglycemic properties of insulin and glucagon. In type-2 diabetic (T2D) subjects, hyperglycemia is largely the consequence of insufficient insulin secretion and excessive glucag Continue reading

Diabetes and Sleep Apnea: What You Need To Know

Diabetes and Sleep Apnea: What You Need To Know

Do you snore? Do you feel fatigued every day? Do you wake up frequently throughout the night? It may be that the shallow breathing or breaks in breathing caused by sleep apnea are the reason. If you have diabetes, it is critical to manage your sleep apnea in order to manage your diabetes. Some 18 million Americans are diagnosed with sleep apnea, but millions more have it and don’t know it.
If you have diabetes, sleep apnea can make it almost impossible for you to manage your diabetes. This is because sleep apnea causes a pause in your breathing while you sleep and increases carbon dioxide in your blood, which leads to:
Insulin resistance so that the body doesn’t use insulin effectively. This causes more sugar in the blood stream leading to high blood sugars
Chronic elevated blood pressure
A higher incidence of heart problems or cardiovascular disease
Early morning headaches
Inadequate rest or sleep can also lead to lack of motivation to exercise or plan meals. This often leads to irritability, which can affect relationships with family, friends and coworkers. Sleepiness also can cause people to forget to take their medications and lead to further diabetes complications.
Sleep apnea may be genetically linked and it is most commonly found in those who are overweight or obese, people who smoke and are over the age of 40.
Could you have an obstruction?
There are different types of sleep apnea, one of which is obstructed sleep apnea (or OSA), which is when breathing is interrupted by a physical block to airflow. With OSA, snoring is common. The National Institutes of Health Continue reading

Differential Weight Loss Effects on Type 2 Diabetes Remission Among Adults

Differential Weight Loss Effects on Type 2 Diabetes Remission Among Adults

An analysis of nationally representative survey-based data finds that 5.2% of adults with type 2 diabetes were in remission, without bariatric surgery, at the end of the second year.
INTRODUCTION: Little is known about the variation in the effect of nonsurgical weight loss among obese and nonobese individuals on the incidence of type 2 diabetes (T2D) remission.
METHODS: Using data from a nationally representative healthcare survey, we analyzed the differential effect of weight loss on the relationship between obesity and the incidence of T2D remission over the span of 1 year among 3755 adults. Anyone who reported having T2D in the first year, but not in the subsequent year, was considered to be in remission. Changes in a person’s weight were measured as change in the body mass index. Data gathered between 2009 and 2013 were analyzed in 2016.
RESULTS: The incidence of self-reported remission was 5.22% (P <.001). Among obese individuals (BMI≥30), those who experiences a 3% drop in weight, at minimum, were 2.1 percentage points more likely to report remission than those who lost less than 3% bodyweight (P <.05). Comparing all individuals who lost more than 3% of their weight with those who lost less than 3% of their weight, obese individuals were 3.7 percentage points more likely than nonobese individuals to report being in remission (P <.05). Furthermore, after accounting for demographic and clinical information, we found that T2D remission was negatively associated with the duration of a T2D diagnosis and diabetes medication type, and was positively associated with being Continue reading

NIHR Signal Type 2 diabetes is becoming more common in children

NIHR Signal Type 2 diabetes is becoming more common in children

The number of children being diagnosed with both type 1 and type 2 diabetes is rising, but new cases of type 2 diabetes, the form associated with being overweight, has risen five-fold in about five years. New analysis in this NIHR-supported study suggest that type 2 diabetes now accounts for up to a third of diabetes diagnoses in children.
Amongst 100,000 school age children about six new cases of type 2 diabetes a year could be expected in the 1990s. This increased to about 33 new cases per year by the end of the next decade (2009 to 2013). Data was taken from the UK Clinical Practice Research Datalink, a primary care database of electronic health records.
Children who are obese have about a four times greater risk of developing type 2 diabetes compared with those of a normal weight. Having type 2 diabetes brings an increased risk of other complications and healthcare problems for individuals and is associated with extra resource use and costs for society.
NICE has produced guidance about preventing type 2 diabetes, but it appears that more needs to be done to promote healthier lifestyles to children and their families. Continue reading

No more pages to load

Popular Articles

Related Articles